NATCOPHARM.NS vs. BYDDY

Last updated Jun 5, 2026

NATCOPHARM.NS (Natco Pharma Limited) and BYDDY (BYD Company Limited ADR) are both stocks. NATCOPHARM.NS operates in Drug Manufacturers - Specialty & Generic (Healthcare), while BYDDY operates in Auto Manufacturers (Consumer Cyclical). Over the past 10 years, NATCOPHARM.NS returned 6.58%/yr vs 24.33%/yr for BYDDY. At a 0.04 correlation, their price movements are largely independent.

Performance

NATCOPHARM.NS vs. BYDDY - Performance Comparison

The chart below illustrates the hypothetical performance of a ₹10,000 investment in Natco Pharma Limited (NATCOPHARM.NS) and BYD Company Limited ADR (BYDDY). The values are adjusted to include any dividend payments, if applicable.

Different Trading Currencies

NATCOPHARM.NS is traded in INR, while BYDDY is traded in USD. To make them comparable, the BYDDY values have been converted to INR using the latest available exchange rates.

Returns By Period

In the year-to-date period, NATCOPHARM.NS achieves a 1.91% return, which is significantly lower than BYDDY's 2.57% return. Over the past 10 years, NATCOPHARM.NS has underperformed BYDDY with an annualized return of 6.58%, while BYDDY has yielded a comparatively higher 24.33% annualized return.

NATCOPHARM.NS

• 1D: -1.69%
• 1M: -18.34%
• YTD: 1.91%
• 6M: -3.05%
• 1Y: 7.58%
• 3Y*: 14.17%
• 5Y*: -1.76%
• 10Y*: 6.58%

BYDDY

• 1D: -0.51%
• 1M: -9.61%
• YTD: 2.57%
• 6M: -1.29%
• 1Y: -24.87%
• 3Y*: 9.63%
• 5Y*: 13.60%
• 10Y*: 24.33%

*Multi-year figures are annualized to reflect compound growth (CAGR)

NATCOPHARM.NS vs. BYDDY - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
NATCOPHARM.NS Natco Pharma Limited	1.91%	-34.53%	71.72%	46.21%	-37.35%	-5.57%	63.99%	-11.63%	-28.51%	67.49%
BYDDY BYD Company Limited ADR	2.57%	13.14%	28.59%	13.84%	-19.34%	30.57%	446.36%	-19.04%	-21.17%	58.59%

Correlation

The correlation between NATCOPHARM.NS and BYDDY is -0.06, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	-0.06
Correlation (3Y) Calculated over the trailing 3-year period	-0.02
Correlation (5Y) Calculated over the trailing 5-year period	0.02
Correlation (10Y) Calculated over the trailing 10-year period	0.04
Correlation (All Time) Calculated using the full available price history since Oct 28, 2008	0.04

The correlation between NATCOPHARM.NS and BYDDY shifts across timeframes, from -0.06 (1 year) to 0.04 (all time), reflecting how their relationship changes across market environments.

Return for Risk

NATCOPHARM.NS vs. BYDDY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NATCOPHARM.NS

NATCOPHARM.NS Risk / Return Rank: 46
NATCOPHARM.NS Sharpe Ratio Rank: 49
NATCOPHARM.NS Sortino Ratio Rank: 43
NATCOPHARM.NS Omega Ratio Rank: 43
NATCOPHARM.NS Calmar Ratio Rank: 49
NATCOPHARM.NS Martin Ratio Rank: 48

BYDDY

BYDDY Risk / Return Rank: 10
BYDDY Sharpe Ratio Rank: 7
BYDDY Sortino Ratio Rank: 8
BYDDY Omega Ratio Rank: 11
BYDDY Calmar Ratio Rank: 8
BYDDY Martin Ratio Rank: 14

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NATCOPHARM.NS vs. BYDDY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Natco Pharma Limited (NATCOPHARM.NS) and BYD Company Limited ADR (BYDDY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	NATCOPHARM.NS	BYDDY	Difference
Sharpe ratio: Return per unit of total volatility	0.20	-0.67	+0.87
Sortino ratio: Return per unit of downside risk	0.55	-0.85	+1.40
Omega ratio: Gain probability vs. loss probability	1.07	0.91	+0.16
Calmar ratio: Return relative to maximum drawdown	0.32	-0.73	+1.05
Martin ratio: Return relative to average drawdown	0.57	-1.10	+1.66
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

NATCOPHARM.NS vs. BYDDY - Sharpe Ratio Comparison

The current NATCOPHARM.NS Sharpe Ratio is 0.20, which is higher than the BYDDY Sharpe Ratio of -0.67. The chart below compares the historical Sharpe Ratios of NATCOPHARM.NS and BYDDY, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	NATCOPHARM.NS	BYDDY	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.20	-0.67	+0.87
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.05	0.30	-0.35
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.20	0.53	-0.33
Sharpe Ratio (All Time) Calculated using the full available price history	0.28	0.25	+0.04

Drawdowns

NATCOPHARM.NS vs. BYDDY - Drawdown Comparison

The maximum NATCOPHARM.NS drawdown since its inception was -89.98%, smaller than the maximum BYDDY drawdown of -97.22%. Use the drawdown chart below to compare losses from any high point for NATCOPHARM.NS and BYDDY.

Drawdown Indicators

	NATCOPHARM.NS	BYDDY	Difference
Max Drawdown Largest peak-to-trough decline	-89.98%	-97.22%	+7.24%
Max Drawdown (1Y) Largest decline over 1 year	-23.82%	-34.24%	+10.42%
Max Drawdown (3Y) Largest decline over 3 years	-53.00%	-39.07%	-13.93%
Max Drawdown (5Y) Largest decline over 5 years	-54.29%	-46.62%	-7.67%
Max Drawdown (10Y) Largest decline over 10 years	-55.44%	-51.46%	-3.98%
Current Drawdown Current decline from peak	-41.82%	-33.23%	-8.59%
Average Drawdown Average peak-to-trough decline	-35.81%	-56.44%	+20.63%
Ulcer Index Depth and duration of drawdowns from previous peaks	13.36%	22.69%	-9.33%

Volatility

NATCOPHARM.NS vs. BYDDY - Volatility Comparison

Natco Pharma Limited (NATCOPHARM.NS) has a higher volatility of 18.16% compared to BYD Company Limited ADR (BYDDY) at 8.80%. This indicates that NATCOPHARM.NS's price experiences larger fluctuations and is considered to be riskier than BYDDY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	NATCOPHARM.NS	BYDDY	Difference
Volatility (1M) Calculated over the trailing 1-month period	18.16%	8.80%	+9.36%
Volatility (6M) Calculated over the trailing 6-month period	29.61%	28.22%	+1.39%
Volatility (1Y) Calculated over the trailing 1-year period	38.00%	37.22%	+0.78%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	34.09%	45.41%	-11.32%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	34.21%	46.47%	-12.26%

Dividends

NATCOPHARM.NS vs. BYDDY - Dividend Comparison

NATCOPHARM.NS's dividend yield for the trailing twelve months is around 0.54%, less than BYDDY's 1.51% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
BYDDY BYD Company Limited ADR	1.51%	1.45%	1.26%	0.60%	0.07%	0.07%	0.03%	0.47%	0.28%	0.52%	1.92%	0.00%
NATCOPHARM.NS Natco Pharma Limited	0.54%	0.55%	0.41%	1.17%	1.11%	0.39%	0.91%	1.18%	1.25%	0.75%	0.35%	0.17%

Financials

Frequently Asked Questions

Can I hold both NATCOPHARM.NS and BYDDY in my portfolio?

NATCOPHARM.NS and BYDDY have a correlation of -0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.